Andrew Hykes - Jul 1, 2024 Form 4 Insider Report for Inari Medical, Inc. (NARI)

Signature
/s/ Shannon Trevino, attorney-in-fact for Andrew Hykes
Stock symbol
NARI
Transactions as of
Jul 1, 2024
Transactions value $
-$362,142
Form type
4
Date filed
7/3/2024, 03:04 PM
Previous filing
May 30, 2024
Next filing
Jul 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Sale -$150K -3K -0.64% $50.08 462K Jul 1, 2024 Direct F1, F2
transaction NARI Common Stock Tax liability -$25.5K -508 -0.11% $50.19 462K Jul 1, 2024 Direct F3
transaction NARI Common Stock Tax liability -$47.5K -947 -0.2% $50.19 461K Jul 1, 2024 Direct F4
transaction NARI Common Stock Tax liability -$74K -1.48K -0.32% $50.19 460K Jul 1, 2024 Direct F5
transaction NARI Common Stock Tax liability -$64.8K -1.29K -0.28% $50.19 458K Jul 1, 2024 Direct F6
holding NARI Common Stock 1.55K Jul 1, 2024 By Child 1
holding NARI Common Stock 1.55K Jul 1, 2024 By Child 2
holding NARI Common Stock 1.55K Jul 1, 2024 By Child 3
holding NARI Common Stock 1K Jul 1, 2024 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2023.
F2 This transaction was executed in multiple trades at prices ranging from $50.00 to $50.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2021.
F4 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2022.
F5 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2023.
F6 Consists of shares of common stock retained by Inari to satisfy the reporting person's tax obligation in connection with the vesting of restricted share units awarded in 2024.